相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 infection: the perspectives on immune responses
Yufang Shi et al.
CELL DEATH AND DIFFERENTIATION (2020)
COVID-19 and African Americans
Clyde W. Yancy
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): A well-mixed SEIR model analysis
Can Hou et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions
Zifeng Yang et al.
JOURNAL OF THORACIC DISEASE (2020)
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
A Simulation on Potential Secondary Spread of Novel Coronavirus in an Exported Country Using a Stochastic Epidemic SEIR Model
Kentaro Iwata et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
Hemalkumar B. Mehta et al.
BMJ OPEN (2020)
A New Method to Determine the Optimal Willingness to Pay in Cost-Effectiveness Analysis
Charles E. Phelps
VALUE IN HEALTH (2019)
Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
Natalie Carvalho et al.
PHARMACOECONOMICS (2018)
Cost Benefit of Comprehensive Primary and Preventive School-Based Health Care
William V. Padula et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2018)
Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
Stephanie F. James et al.
ANNALS OF PHARMACOTHERAPY (2018)
Adding Cost-effectiveness to Define Low-Value Care
Ankur Pandya
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review
Jamison Pike et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2018)
Economic Analysis of Vaccination Programs
Josephine Mauskopf et al.
VALUE IN HEALTH (2018)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Quantifying the Economic Value and Quality of Life Impact of Earlier Influenza Vaccination
Bruce Y. Lee et al.
MEDICAL CARE (2015)
Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
Thomas J. Hoerger et al.
DIABETES CARE (2013)
Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand
M. Sharma et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
Measured Dynamic Social Contact Patterns Explain the Spread of H1N1v Influenza
Ken T. D. Eames et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Herd Immunity'': A Rough Guide
Paul Fine et al.
CLINICAL INFECTIOUS DISEASES (2011)
Medicare Part D and the Financial Protection of the Elderly
Gary V. Engelhardt et al.
AMERICAN ECONOMIC JOURNAL-ECONOMIC POLICY (2011)
Barriers to the Use of Herpes Zoster Vaccine
Laura P. Hurley et al.
ANNALS OF INTERNAL MEDICINE (2010)
Extending influenza vaccination to individuals aged 50-64: A budget impact analysis
Americo Cicchetti et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2010)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Preference-based EQ-5D index scores for chronic conditions in the United States
Patrick W. Sullivan et al.
MEDICAL DECISION MAKING (2006)
A national catalog of preference-based scores for chronic conditions in the United States
PW Sullivan et al.
MEDICAL CARE (2005)
US valuation of the EQ-5D health states - Development and testing of the D1 valuation model
JW Shaw et al.
MEDICAL CARE (2005)
Managing febrile respiratory illnesses during a hypothetical SARS outbreak
K Khan et al.
EMERGING INFECTIOUS DISEASES (2005)
Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease
AH Briggs et al.
MEDICAL DECISION MAKING (2002)
Handling uncertainty in cost-effectiveness models
AH Briggs
PHARMACOECONOMICS (2000)
分享论文
